EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dyslipidaemia in Rheumatological Autoimmune Diseases

Tracey E Toms, Vasileios F Panoulas, George D Kitas

The Open Cardiovascular Medicine Journal · 24.02.2011 · 5 (1) · 64-75

DOI: 10.2174/1874192401105010064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Open Cardiovascular Medicine Journal, erschienen am 24.02.2011. Verfasst von Tracey E Toms und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Dudley, West Midlands, UK. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmunity forms the basis of many rheumatological diseases, and may contribute not only to the classical clinical manifestations but also to the complications. Many of the autoimmune rheumatological diseases, including rheumatoid arthritis and systemic lupus erythematosus are associated with an excess cardiovascular morbidity and mortality. Much of this excess cardiovascular risk can be attributed to atherosclerotic disease. Atherosclerosis is a complex pathological process, with dyslipidaemia and inflammation fundamental to all stages of plaque evolution. The heightened inflammatory state seen in conjunction with many rheumatological diseases may accelerate plaque formation, both through direct effects on the arterial wall and indirectly through inflammation-mediated alterations in the lipid profile. Alongside these factors, antibodies produced as part of the autoimmune nature of these conditions may lead to alterations in the lipid profile and promote atherosclerosis. In this review, we discuss the association between several of the rheumatological autoimmune diseases and dyslipidaemia, and the potential cardiovascular impact this may confer.

Schlagwörter

Stichwörter der Autor:innen

Autoimmune diseaseanti-phospholipid syndrome.dyslipidaemiaprimary sjogrens syndromerheumatoid arthritissystemic lupus erythematosussystemic sclerosis

Autor:innen und Institutionen

  • Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Dudley, West Midlands, UK.

Zitieren

APA

Toms, T. E., Panoulas, V. F., & Kitas, G. D. (2011). Dyslipidaemia in Rheumatological Autoimmune Diseases. The Open Cardiovascular Medicine Journal, 5(1), 64-75. https://doi.org/10.2174/1874192401105010064

Vancouver

Toms TE, Panoulas VF, Kitas GD. Dyslipidaemia in Rheumatological Autoimmune Diseases. The Open Cardiovascular Medicine Journal. 2011;5(1):64-75. doi:10.2174/1874192401105010064

BibTeX
@article{Toms2011,
  author = {Toms, Tracey E and Panoulas, Vasileios F and Kitas, George D},
  title = {Dyslipidaemia in Rheumatological Autoimmune Diseases},
  journal = {The Open Cardiovascular Medicine Journal},
  year = {2011},
  volume = {5},
  number = {1},
  pages = {64--75},
  doi = {10.2174/1874192401105010064}
}
Kostenlos starten →